Related Experiment Videos
[Characteristics and indications of topiramate]
1Servicio de Neuropediatría. Hospital Infantil Universitario Virgen del Rocio, Sevilla, España. med000600@saludalia.com
Revista De Neurologia
|October 10, 2002
Summary
Topiramate (TPM) is an effective antiepileptic medication for various childhood epilepsies, including partial epilepsy in monotherapy. TPM also shows promise for migraines, mood disorders, and neuropathic pain.
Area of Science:
- Neurology
- Pharmacology
Background:
- Topiramate (TPM) is an antiepileptic medication (AEM) with diverse mechanisms of action and favorable pharmacokinetics.
- Its efficacy in various neurological and psychiatric conditions requires comprehensive evaluation.
Purpose of the Study:
- To assess the efficiency of TPM in different types of childhood epilepsy.
- To evaluate TPM's utility in migraines, bipolar disorder, eating disorders, and neuropathic pain.
Main Methods:
- Literature analysis and a multicenter study in Spain were conducted.
- Patient response was measured by seizure freedom and >50% seizure frequency reduction.
- Evaluated conditions included various epilepsy syndromes (e.g., Lennox Gastaut, West, Dravet) and other disorders.
Main Results:
- Monotherapy for partial epilepsy resulted in 39-54% seizure-free patients.
- TPM demonstrated efficacy in animal models as a neuroprotector.
- Clinical trials indicated effectiveness in type I bipolar disorder, eating disorders, neuropathic pain, and migraine.
Conclusions:
- TPM is an effective AEM with a broad therapeutic spectrum, useful as adjunctive therapy for epilepsy syndromes.
- It is particularly effective as a first-line monotherapy for partial epilepsy.
- TPM shows potential in mood disorders, eating disorders, and neuropathic pain, with proven efficacy in migraine and neuroprotective effects.